Investors.com will undergo scheduled maintenance from 10:00 PM ET to 2:00 AM ET and some features may be unavailable. We apologize for any inconvenience.
Kiniksa Pharmaceuticals (KNSA) shares currently hover just below a buy point, making the biotech stock Tuesday’s choice for IBD 50 Stocks To Watch. The Lexington, Mass.-based drugmaker focuses on treatments for rare diseases. Its primary drug Arcalyst treats recurring pericarditis, a heart disease caused by an autoimmune condition. The condition leads to fluid buildup around the heart or changes in…
Related news
IBD 50 Growth Stocks To Watch
6/16/2025 Get timely chart analysis and investing lessons on leading stocks that have earned a spot on the IBD 50, an…
6/16/2025 Get timely chart analysis and investing lessons on leading stocks…
